Identification of methicillin-resistant isolates of Staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix™ system

Diagnostic Microbiology and Infectious Disease

Volumn 48, Issue 4, 2004, Pages 221-227

  Spanu, Teresa ^a   Sanguinetti, Maurizio ^a   D'Inzeo, Tiziana ^a   Ciccaglione, Daniela ^a   Romano, Lucio ^a   Leone, Fiammetta ^a   Mazzella, Patrizia ^a   Fadda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Methicillin resistance; Staphylococcal bloodstream isolates

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD FLOW; COAGULASE NEGATIVE STAPHYLOCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; COAGULASE; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; REAGENT KITS, DIAGNOSTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 1942503336     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2003.11.004     Document Type: Article

References (46)

1. th ed. Churchill Livingstone, pp. 1777-1783.
2. Archer G.L., Climo M.W. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother. 38:1994;2231-2237.
3. Archer G.L., Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother. 34:1990;1720-1724.
4. Almer, L. S., Shortridge, V. D., Nilius, A. M., Beyer, J. M., Soni, N. B., B. E., Bui, M. H., Stone, G. G., & Flamm, R. K. (2002). Antimicrobial susceptibility and molecular characterisation of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 43, 225-232.
5. Arbique J., Forward K., Haldane D., Davidson R. Comparison of Velogene Rapid MRSA Identification Assay, Denka MRSA-screen Assay and BBL Crystal MRSA ID System for rapid Identification of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis. 40:2001;5-10.
6. Barenfanger J., Drake C., Kacich G. Clinical and financial benefits of rapid bacterial identifications and antimicrobial susceptibility testing. J Clin Microbiol. 37:1999;1415-1418.
7. Baron E.J. Genetic aspects of methicillin resistance in Staphylococcus aureus and methods used for its detection in clinical laboratories in the United States. J Chemother. 7:(Suppl):1995;87-92.
8. Bekkaoui F., McNevin J.P., Leung C.H., Peterson G.J., Patel A., Bhatt R.S., Bryan R.N. Rapid detection of mecA gene in methicillin resistant staphylococci using a colorimetric cycling probe technology. Diagn Microbiol Infect Dis. 34:1999;83-90.
9. Benjamin D.K., Miller W., Garges H., Benjamin D.K., McKinney R.E., Cotton M., Fisher R.G., Alexander K.A. Bacteremia, central catheters and neonates when to pull the line. Pediatrics. 107:2001;1272-1276.
10. Brown D.F.J. Detection of methicillin/oxacillin resistance in staphylococci. J Antimicrob Chemother. 48:2001;65-70.
11. Chambers H.F. Methicillin resistance in staphylococci molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 10:1997;781-791.
12. Cloney L., Marlowe C., Wong A., Chow R., Bryan R. Rapid detection of mecA in methicillin resistant Staphylococcus aureus using cycling probe technology. Mol Cell Probes. 13:1999;191-197.
13. Cormican M.G., Wilke W.W., Barret M.S., Pfaller M.A., Jones R.N. Phenotypic detection of mecA-positive staphylococcal bloodstream isolates high accuracy of simple diffusion test. Diagn Microbiol Infect Dis. 25:1996;107-112.
14. Coudron P.E., Jones D.L., Dalton H.P., Archer G.L. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Clin Microbiol. 24:1986;764-769.
15. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., Beach M., SENTRY Participants Group. Survey of infections due to Staphylococcus species frequency of occurrence, and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and Western Pacific region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis. 32:(Suppl):2001;114-132.
16. Doern G.V., Vautar R., Gaudet M., Levy B. Clinical impact of in vitro susceptibility testing and bacterial identification. J Clin Microbiol. 32:1994;1757-1762.
17. Endimiani A., Luzzaro F., Tamborini A., Lombardi G., Elia V., Belloni R., Toniolo A. Identification and antimicrobial susceptibility testing of clinical isolates of non fermenting gram-negative bacteria by the Phoenix automated microbiology system. New Microbiol. 25:2002;323-329.
18. Fahr A.M., Eigner U., Armbrust M., Caganic A., Dettori G., Chezzi C., Bertoncini L., Benecchi M., Menozzi M.G. Two center collaborative evaluation of the performance of the B.D. Phoenix Automated Microbiology system for identification and antimicrobial susceptibility testing of Enterococcus and Staphylococcus spp. J Clin Microbiol. 41:2003;1135-1142.
19. Felten A., Grandry B., Lagrange P.H., Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA) a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system and the MRSA-Screen latex agglutination test. J Clin Microbiol. 40:2002;2766-2771.
20. Garner J.S., Jarvis W.R., Emory T.G., Horan T.C., Hughes J.M. CDC definition for nosocomial infections. Am J Infect Control. 16:1988;128-140.
21. Geha D.J., Uhl J.R., Gustaferro C.A., Persing D.H. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol. 32:1994;1768-1772.
22. Herold B.C., Immergluck L.C., Maranan M.C., Laudarle D.S., Gaskin R.E., Boyle-Vaira S., Leitch C.D., Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 279:1998;593-598.
23. Horstkotte M.A., Knobloch J.K., Rhode H., Dobinsky S., Mack D. Rapid detection of methicillin resistance in coagulase-negative staphylococci with the VITEK 2 system. J Clin Microbiol. 40:2002;3291-3295.
24. Kim S.D., Mc Donald L.C., Jarvis W.R., McAllister S.K., Jerris R., Carson L.A., Miller J.M. Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community hospital a role for species and strain identification. Infect Control Hosp Epidemiol. 21:2000;213-217.
25. Kloos W.E., Bannerman T.L. Staphylococcus and micrococcus. Murray P.R., Baron E.J., Pfaller M.A., et al. Manual of Clin Microbiol. 1999;271-275 ASM press, Washington.
26. Kohner P., Uhl J., Kolbert C., Persing D., Cocherill F. Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase negative Staphylococcus spp. J Clin Microbiol. 37:1999;2952-2961.
27. Leverstein-van Hall M.A., Fluit A.C., Paauw A., Box A.T., Brisse S., Verhoef J. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol. 40:2002;3703-3711.
28. Liu H., Buescher G., Levis N., Snyder S., Jungkind D. Detection of bordeline oxacillin-resistant Staphylococcus aureus and differentiation of methicillin-resistant strains. Eur J Clin Microbiol Infect Dis. 9:1990;717-724.
29. Livermore D.M. Antibiotic resistance in staphylococci. Internat J Antimicrob Agents. 16:(Suppl):2000;3-10.
30. Marshall S.A., Wilke W.W., Pfaller M.A., Jones R.N. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program. Diagn Microbiol Infect Dis. 30:1998;205-214.
31. McDonald C.L., Maher W.E., Fass R.J. Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection. Antimicrob Agents Chemother. 39:1995;982-984.
32. Mulder J.G. Comparison of disk diffusion, the E-test, and detection of mecA for determination of methicillin resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis. 15:1996;567-573.
33. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement M100-S12. 2002;National Committee for Clinical Laboratory Standards, Villanova, PA.
34. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement M100-S8. 1998;National Committee for Clinical Laboratory Standards, Villanova, PA.
35. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. Survey of blood stream infections attributable to gram-positive cocci frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn Microbiol Infect Dis. 33:1999;283-297.
36. Renneberg J., Rieneck K., Gutschik E. Evaluation of STAPH ID 32 system and Staph-Zym system for identification of coagulase-negative staphylococci. J Clin Microbiol. 33:1995;1150-1153.
37. Sakoulas G., Gold H.S., Venkataraman L., DeGirolami P.C., Eliopoulos G.M., Qian Q. Methicillin-resistant Staphylococcus aureus comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol. 39:2001;3946-3951.
38. Sanguinetti M., Posteraro B., Spanu T., Ciccaglione D., Romano L., Fiori B., Nicoletti G., Zanetti S., Fadda G. Characterization of clinical strains of Enterobacteriaceae isolated at a teaching hospital in Italy using Phoenix extended-spectrum β-lactamase detection method. J Clin Microbiol. 41:2003;1463-1468.
39. Sturenburg E., Sobottka I., Feucht H.H., Mack D., Laufs R. Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum β-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn Microbiol Infect Dis. 45:2003;29-34.
40. Tenover F.C., Jones R.N., Swenson J.M., Zimmer B., McAllister S., Jorgensen J.H., National Committee for Clinical Laboratory Standards Staphylococcus working group. Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci results of a multicenter study. J Clin Microbiol. 37:1999;4051-4058.
41. Tomasz A., Drugeon H.B., de Lencastre H.M., Jabes D., McDougall L., Bille J. New mechanism for methicillin resistance in Staphylococcus aureus clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother. 33:1989;1869-1874.
42. Tomasz A., Nachman S., Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother. 35:1991;124-129.
43. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V.T., Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis. 13:1994;50-55.
44. Yamazumi T., Furuta I., Diekema D.J., Pfaller M.A., Jones R.N. Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol. 39:2001;3633-3636.
45. Yamazumi T., Marshall S.A., Wilke W.W., Diekema D.J., Pfaller M.A., Jones R.N. Comparison of the Vitek Gram-positive susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J Clin Microbiol. 39:2001;53-56.
46. Yugueros J., Temprano A., Berzal B., Sanchez M., Hernanz C., Luengo J.M., Naharro G. Glyceraldehyde-3-phospate dehydrogenase-encoding gene as a useful taxonomic tool for Staphylococcus spp. J Clin Microbiol. 38:2000;4351-4355.